US Patent 10519251 Fabs-in-tandem immunoglobulin and uses thereof
Patent 10519251 was granted and assigned to EpimAb Biotherapeutics on December, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10519251 Fabs-in-tandem immunoglobulin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
